Qualigen Therapeutics (QLGN) News Today $4.16 -0.24 (-5.45%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$4.06 -0.10 (-2.40%) As of 10/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QLGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Qualigen Therapeutics (NASDAQ:QLGN) Raised to Sell at Wall Street ZenOctober 11 at 2:54 AM | americanbankingnews.comQualigen Therapeutics, Inc. Announces Leadership and Governance Changes to Support Strategic GrowthOctober 6, 2025 | quiverquant.comQQualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor TransitionOctober 6, 2025 | globenewswire.comUnivest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)September 30, 2025 | globenewswire.comQualigen Therapeutics stock soars after closing $41M PIPE financingSeptember 30, 2025 | investing.comQualigen Therapeutics closes $41M PIPE financing led by Faraday FutureSeptember 30, 2025 | msn.comQualigen Therapeutics shares spike after securing $41M PIPE financingSeptember 30, 2025 | msn.comQualigen Therapeutics, Inc. Announces $41 Million PIPE Financing for Strategic Shift to Web3 and Crypto BusinessSeptember 30, 2025 | quiverquant.comQQualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into CryptoSeptember 30, 2025 | globenewswire.comThis Penny Stock Is Surging Big Time on a Tie-Up With Faraday Future and a Push Into Crypto. Should You Buy Its Shares Here?September 24, 2025 | msn.comQualigen Therapeutics stock soars after Faraday Future announces $30M investmentSeptember 22, 2025 | ca.investing.comWhy Is Qualigen Therapeutics’ Stock Surging Nearly 300% Premarket?September 22, 2025 | msn.comFaraday Future announces $41M investment in Qualigen TherapeuticsSeptember 19, 2025 | msn.comFaraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE TransactionSeptember 19, 2025 | globenewswire.comQualigen Therapeutics files to sell 3.21M shares of common stock for holdersSeptember 16, 2025 | msn.comQualigen Therapeutics Amends Promissory Note with MarizymeSeptember 16, 2025 | tipranks.comQualigen Therapeutics Amends Promissory Note with MarizymeAugust 27, 2025 | tipranks.comQualigen Therapeutics, Inc.: Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing StatusJuly 30, 2025 | finanznachrichten.deQualigen Therapeutics Announces $4.5M Private PlacementJuly 29, 2025 | msn.comQualigen Therapeutics provides update on Nasdaq listing statusJuly 28, 2025 | msn.comQualigen Therapeutics Secures Nasdaq Compliance ExtensionJuly 28, 2025 | msn.comQualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing StatusJuly 28, 2025 | finance.yahoo.comQualigen Therapeutics, Inc. Secures $4.5 Million Through Series A-3 Preferred Stock Private PlacementJuly 28, 2025 | quiverquant.comQQualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred StockJuly 28, 2025 | globenewswire.comQualigen Therapeutics shares surge after patent approvals in 25 countriesJuly 16, 2025 | msn.comQualigen Therapeutics, Inc. (QLGN) - Yahoo FinanceJune 25, 2025 | finance.yahoo.comQualigen Therapeutics faces potential Nasdaq delistingMay 21, 2025 | uk.investing.comQualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to ...May 19, 2025 | gurufocus.comQualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to ...May 19, 2025 | gurufocus.comQualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to ...May 19, 2025 | gurufocus.comQualigen Therapeutics Faces Nasdaq Delisting NotificationMay 19, 2025 | tipranks.comQualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-QMay 19, 2025 | globenewswire.comMarizyme, Inc. (MRZM) Latest Press Releases & Corporate News - Yahoo FinanceMay 10, 2025 | finance.yahoo.comQualigen Therapeutics Faces Nasdaq Delisting ThreatMay 1, 2025 | tipranks.comQualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-KMay 1, 2025 | globenewswire.comQualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire MarizymeApril 1, 2025 | finance.yahoo.comQualigen Therapeutics Delays Yearly Financial ReportApril 1, 2025 | tipranks.comQualigen Therapeutics to participate in next funding round for NanoSynexJanuary 28, 2025 | markets.businessinsider.comQualigen to invest in NanoSynex, stock tumbles 21%January 28, 2025 | msn.comQualigen to participate in next funding round for NanoSynexJanuary 28, 2025 | markets.businessinsider.comQualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity RequirementDecember 6, 2024 | markets.businessinsider.comUnivest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)November 25, 2024 | globenewswire.comQualigen Therapeutics secures $4.5 million in fundingNovember 21, 2024 | investing.comQualigen announces $4.5M private placement of Preferred SharesNovember 20, 2024 | markets.businessinsider.comQualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred SharesNovember 20, 2024 | finance.yahoo.comQualigen Therapeutics Appoints Graydon Bensler to BoardNovember 15, 2024 | markets.businessinsider.comQualigen Therapeutics trading halted, news pendingNovember 5, 2024 | markets.businessinsider.comQualigen Therapeutics Announces 1-for-50 Reverse Stock SplitNovember 1, 2024 | markets.businessinsider.comShares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024November 1, 2024 | globenewswire.comQualigen Therapeutics, Inc. Announces management changes.September 26, 2024 | globenewswire.com Get Qualigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QLGN Media Mentions By Week QLGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QLGN News Sentiment▼0.780.77▲Average Medical News Sentiment QLGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QLGN Articles This Week▼51▲QLGN Articles Average Week Get the Latest News and Ratings for QLGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PYRGF News Today AKTX News Today GLTO News Today IMA News Today SCYX News Today PMN News Today DARE News Today RNTX News Today CVKD News Today LPTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:QLGN) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
